TP53 and glioblastoma: A series of oncogenic pathways in GBM including the p53, the retinoblastoma tumor suppressor (RB), and the receptor tyrosine kinases/RAS/phosphatidylinositol 3 kinase (RTK/RAS/PI3K) pathways are activated in majority of cases [16].